Insider Transactions in Q1 2024 at Acrivon Therapeutics, Inc. (ACRV)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.53%
|
$651
$3.4 P/Share
|
|
Feb 14
2024
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
468
-2.51%
|
$1,404
$3.4 P/Share
|
|
Feb 14
2024
|
Rasmus Holm Jorgensen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-1.55%
|
$1,302
$3.4 P/Share
|
|
Feb 14
2024
|
Kristina Masson EVP - Business Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
579
-0.18%
|
$1,737
$3.4 P/Share
|
|
Feb 14
2024
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,861
-1.57%
|
$125,583
$3.4 P/Share
|
|
Feb 14
2024
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
723
-1.2%
|
$2,169
$3.4 P/Share
|
|
Jan 17
2024
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
652
-1.58%
|
$2,608
$4.35 P/Share
|